vs
Side-by-side financial comparison of Montauk Renewables, Inc. (MNTK) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($60.1M vs $43.4M, roughly 1.4× Montauk Renewables, Inc.). Montauk Renewables, Inc. runs the higher net margin — 5.7% vs -92.6%, a 98.3% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 56.7%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs 5.8%).
Montauk Renewables, Inc. is a US-based renewable energy firm specializing in capturing and converting biogenic methane from landfills and agricultural waste into renewable natural gas (RNG) and low-carbon electricity. It serves utility, commercial, and industrial customers across North America, with operations focused on advancing decarbonization and sustainable energy transition goals.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
MNTK vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $43.4M | $60.1M |
| Net Profit | $2.5M | $-55.6M |
| Gross Margin | — | 88.1% |
| Operating Margin | -3.8% | -87.1% |
| Net Margin | 5.7% | -92.6% |
| Revenue YoY | 56.7% | 83.8% |
| Net Profit YoY | 129.5% | — |
| EPS (diluted) | $0.01 | $-0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $60.1M | ||
| Q4 25 | $43.4M | $57.3M | ||
| Q3 25 | $45.3M | $51.3M | ||
| Q2 25 | $45.1M | $48.5M | ||
| Q1 25 | $42.6M | $32.7M | ||
| Q4 24 | $27.7M | $41.8M | ||
| Q3 24 | $65.9M | $33.3M | ||
| Q2 24 | $43.3M | $29.1M |
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $2.5M | $-47.5M | ||
| Q3 25 | $5.2M | $-52.9M | ||
| Q2 25 | $-5.5M | $-46.6M | ||
| Q1 25 | $-464.0K | $-49.5M | ||
| Q4 24 | $-8.5M | $-43.3M | ||
| Q3 24 | $17.0M | $-43.6M | ||
| Q2 24 | $-712.0K | $-32.3M |
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | 43.8% | 88.5% | ||
| Q2 24 | 15.6% | 89.9% |
| Q1 26 | — | -87.1% | ||
| Q4 25 | -3.8% | -82.2% | ||
| Q3 25 | 9.8% | -102.6% | ||
| Q2 25 | -5.2% | -93.4% | ||
| Q1 25 | 1.0% | -143.7% | ||
| Q4 24 | -35.5% | -98.6% | ||
| Q3 24 | 34.4% | -132.0% | ||
| Q2 24 | 2.0% | -139.2% |
| Q1 26 | — | -92.6% | ||
| Q4 25 | 5.7% | -83.0% | ||
| Q3 25 | 11.5% | -103.1% | ||
| Q2 25 | -12.2% | -96.1% | ||
| Q1 25 | -1.1% | -151.4% | ||
| Q4 24 | -30.5% | -103.6% | ||
| Q3 24 | 25.9% | -131.2% | ||
| Q2 24 | -1.6% | -110.9% |
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $0.01 | $-0.73 | ||
| Q3 25 | $0.04 | $-0.82 | ||
| Q2 25 | $-0.04 | $-0.75 | ||
| Q1 25 | $0.00 | $-0.81 | ||
| Q4 24 | $-0.05 | $-0.71 | ||
| Q3 24 | $0.12 | $-0.73 | ||
| Q2 24 | $-0.01 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.8M | $340.6M |
| Total DebtLower is stronger | $126.0M | — |
| Stockholders' EquityBook value | $263.1M | $122.9M |
| Total Assets | $435.5M | $442.3M |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $340.6M | ||
| Q4 25 | $23.8M | $388.9M | ||
| Q3 25 | $6.8M | $416.1M | ||
| Q2 25 | $29.1M | $291.0M | ||
| Q1 25 | $40.1M | $314.5M | ||
| Q4 24 | $45.6M | $320.6M | ||
| Q3 24 | $55.0M | $298.4M | ||
| Q2 24 | $42.3M | $319.1M |
| Q1 26 | — | — | ||
| Q4 25 | $126.0M | — | ||
| Q3 25 | $54.9M | — | ||
| Q2 25 | $57.8M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $43.8M | — | ||
| Q3 24 | $46.7M | — | ||
| Q2 24 | $49.7M | — |
| Q1 26 | — | $122.9M | ||
| Q4 25 | $263.1M | $139.1M | ||
| Q3 25 | $260.7M | $148.8M | ||
| Q2 25 | $254.7M | $-11.9M | ||
| Q1 25 | $258.2M | $18.9M | ||
| Q4 24 | $257.4M | $21.7M | ||
| Q3 24 | $275.3M | $11.2M | ||
| Q2 24 | $255.3M | $39.3M |
| Q1 26 | — | $442.3M | ||
| Q4 25 | $435.5M | $480.2M | ||
| Q3 25 | $383.3M | $506.9M | ||
| Q2 25 | $382.5M | $372.7M | ||
| Q1 25 | $354.2M | $386.7M | ||
| Q4 24 | $349.0M | $392.3M | ||
| Q3 24 | $374.1M | $363.6M | ||
| Q2 24 | $362.0M | $381.8M |
| Q1 26 | — | — | ||
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $337.0K | — |
| Free Cash FlowOCF − Capex | $-41.1M | — |
| FCF MarginFCF / Revenue | -94.7% | — |
| Capex IntensityCapex / Revenue | 95.5% | — |
| Cash ConversionOCF / Net Profit | 0.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-86.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $337.0K | $-25.4M | ||
| Q3 25 | $12.7M | $-26.6M | ||
| Q2 25 | $8.2M | $-23.3M | ||
| Q1 25 | $9.1M | $-40.4M | ||
| Q4 24 | $724.0K | $-18.8M | ||
| Q3 24 | $28.6M | $-25.2M | ||
| Q2 24 | $193.0K | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-41.1M | — | ||
| Q3 25 | $-17.2M | — | ||
| Q2 25 | $-25.5M | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | $-8.3M | — | ||
| Q3 24 | $16.0M | — | ||
| Q2 24 | $-18.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | -94.7% | — | ||
| Q3 25 | -37.9% | — | ||
| Q2 25 | -56.4% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | -29.8% | — | ||
| Q3 24 | 24.3% | — | ||
| Q2 24 | -42.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 95.5% | — | ||
| Q3 25 | 65.9% | — | ||
| Q2 25 | 74.6% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 32.5% | — | ||
| Q3 24 | 19.1% | — | ||
| Q2 24 | 43.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 2.43× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MNTK
| Natural Gas Environmental Attributes | $28.1M | 65% |
| Natural Gas Commodity | $10.7M | 25% |
| Electric Commodity | $2.7M | 6% |
| Electric Environmental Attributes | $2.0M | 5% |
RYTM
Segment breakdown not available.
